Cabrera O - Search Results

1

Mucosal and systemic immune responses induced by a single time vaccination strategy in mice.

González Aznar E, Romeu B, Lastre M, Zayas C, Cuello M, Cabrera O, Valdez Y, Fariñas M, Pérez O. González Aznar E, et al. Among authors: cabrera o. Can J Microbiol. 2015 Aug;61(8):531-8. doi: 10.1139/cjm-2015-0063. Epub 2015 May 19. Can J Microbiol. 2015. PMID: 26140382

2

Mucosal immune responses to meningococcal C polysaccharide-protein conjugate in mice.

Cuello M, Cabrera O, del Campo JM, Parajón E, Sotolongo F, Camaraza MA, Arnet A, Suárez M, Pérez O. Cuello M, et al. Among authors: cabrera o. Vaccine. 2006 Apr 12;24 Suppl 2:S2-72-3. doi: 10.1016/j.vaccine.2005.01.129. Vaccine. 2006. PMID: 16823934

3

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

Campo JD, Zayas C, Romeu B, Acevedo R, González E, Bracho G, Cuello M, Cabrera O, Balboa J, Lastre M. Campo JD, et al. Among authors: cabrera o. Methods. 2009 Dec;49(4):301-8. doi: 10.1016/j.ymeth.2009.03.025. Epub 2009 May 4. Methods. 2009. PMID: 19410000

4

Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.

Romeu B, González E, Del Campo J, Acevedo R, Zayas C, Valdés Y, Cabrera O, Cuello M, Balboa J, Lastre M, Pérez O. Romeu B, et al. Among authors: cabrera o. Can J Microbiol. 2011 Mar;57(3):256-61. doi: 10.1139/W11-002. Can J Microbiol. 2011. PMID: 21358768

5

AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.

Romeu B, González E, Zayas C, Del Campo J, Acevedo R, Cuello M, Valdes Y, Balboa J, Cabrera O, Lastre M, Pérez O. Romeu B, et al. Among authors: cabrera o. Scand J Infect Dis. 2011 Oct;43(10):809-13. doi: 10.3109/00365548.2011.586648. Epub 2011 Jun 15. Scand J Infect Dis. 2011. PMID: 21671827

6

The golden era of vaccine adjuvants.

Cabrera O, Cuello M, Lastre M, Romeu B, Balboa J, Zayas C, Pérez O. Cabrera O, et al. Expert Rev Vaccines. 2011 Jul;10(7):1007-9. doi: 10.1586/erv.11.62. Expert Rev Vaccines. 2011. PMID: 21806395 Free article.

7

New vaccines require potent adjuvants like AFPL1 and AFCo1.

Pérez O, Lastre M, Cabrera O, del Campo J, Bracho G, Cuello M, Balboa J, Acevedo R, Zayas C, Gil D, Mora N, González D, Pérez R, González E, Barberá R, Fajardo EM, Sierra G, Solís RL, Campa C. Pérez O, et al. Among authors: cabrera o. Scand J Immunol. 2007 Aug-Sep;66(2-3):271-7. doi: 10.1111/j.1365-3083.2007.01981.x. Scand J Immunol. 2007. PMID: 17635804 Free article.

8

Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.

Pérez O, Batista-Duharte A, González E, Zayas C, Balboa J, Cuello M, Cabrera O, Lastre M, Schijns VE. Pérez O, et al. Among authors: cabrera o. Braz J Med Biol Res. 2012 Aug;45(8):681-92. doi: 10.1590/s0100-879x2012007500067. Epub 2012 Apr 26. Braz J Med Biol Res. 2012. PMID: 22527130 Free PMC article. Review.

9

Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid.

Balboa JA, Cuello M, Cabrera O, del Campo J, Lastre M, Gil D, Taboada C, Fariñas M, Hernández M, Pérez O. Balboa JA, et al. Among authors: cabrera o. Vaccine. 2006 Apr 12;24 Suppl 2:S2-63-4. doi: 10.1016/j.vaccine.2005.01.125. Vaccine. 2006. PMID: 16823931

10

New method for obtaining conjugated vaccines.

Cabrera O, Cuello M, Soto CR, Martínez ME, del Campo JM, Pérez Oa, Infante JF, Sierra G. Cabrera O, et al. Vaccine. 2006 Apr 12;24 Suppl 2:S2-76-8. doi: 10.1016/j.vaccine.2005.01.131. Vaccine. 2006. PMID: 16823936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters